Fat free mass and exacerbation of chronic obstructive pulmonary disease

R. Baghai-Ravary, J. Quint, G. Donaldson, J. Wedzicha (London, United Kingdom)

Source: Annual Congress 2007 - COPD and comorbidity
Session: COPD and comorbidity
Session type: Electronic Poster Discussion
Number: 4158
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Baghai-Ravary, J. Quint, G. Donaldson, J. Wedzicha (London, United Kingdom). Fat free mass and exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2007; 30: Suppl. 51, 4158

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Body composition and pulmonary function in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 626s
Year: 2006

Visceral adiposity index in patients with chronic obstructive pulmonary disease
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018


Body composition in chronic obstructive pulmonary disease and heart failure
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018

Body composition in heart failure and chronic obstructive pulmonary disease patients
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017


Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

The ”gas-respiratory[dcdquote] index and chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 242s
Year: 2003

Systemic effects of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 347-360
Year: 2003



Change in muscle mass in training patients with chronical obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005

Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Minimal bronchiectasis in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009

Disease of the airways in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 41S-49S
Year: 2001



Inflammation and depression in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 718s
Year: 2007

Emphysema contribution to the progression of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 654s
Year: 2006

Systemic inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 5S-13S
Year: 2003



Association between percentage of  fat mass  and endothelial function in patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients
Source: Eur Respir J 2003; 21: 58-67
Year: 2003



Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective
Source: Eur Respir J 2003; 22: 2S-4S
Year: 2003



Determinants of depression at exacerbation in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Energy expenditure in stable chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 182s
Year: 2005

Creatinine-height index, pulmonary function and dyspnoa in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005